|
CR243b : Cervix squamous cell carcinoma with normal adjacent cervix tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores（1.5mm）, replacing CR243a
Description
| Microarray Panel |
Cervix squamous cell carcinoma with normal adjacent cervix tissue microarray, containing 18 cases of squamous cell carcinoma, 6 normal adjacent tissue, duplicated cores per case, 2 serial sections, divided into two identical 24 core arrays for testing different antibody dilutions |
| Cores |
48 |
|
| Cases |
24 |
| Row number |
4 |
| Column number |
12 |
| Core Diameter (mm) |
1.5 |
| Thickness (µm) |
5 |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: CR243b
- Availability: In Stock
|
Tags:
With normal control,
Duplicate cores per case,
Stage (TNM)
- Malignant tumor,
- Malignant tumor (stage I),
- Malignant tumor (stage IA),
- Malignant tumor (stage IB),
- Malignant tumor (stage II),
- Malignant tumor (stage IIIB),
- NAT